施万细胞的自:在糖尿病外围神经病变中是一种潜在的药物治疗点
Qi-Chang Xing1, Jia Chen2, Zheng Liu2
1Department of Clinical Pharmacy, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan 411100, Hunan Province, China. 67324457@qq.com.
World journal of diabetes
|June 23, 2025
概括
针对施万细胞 (SCs) 中的细胞降解 (自) 显示出治疗糖尿病外围神经病变 (DPN) 的前景. 调节自途径可以恢复神经功能,并促进DPN患者的再生.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病外围神经病变 (DPN) 涉及由于糖尿病而导致的神经损伤,危及施万细胞 (SCs).
- 在高血糖症下的SC功能障碍会损害神经再生,并导致脱髓化.
- 自,一个关键的细胞过程,对于SC功能和DPN进展至关重要.
研究的目的:
- 要突出自性在SCs对于DPN的意义.
- 探索自作为DPN的药物治疗点.
- 审查调节DPN治疗自的药物.
主要方法:
- 讨论了SC中自的机制,包括关键的信号通路 (例如AMPK/mTOR).
- 检查了调节自的自然产品和化学剂.
- 探索了外体,lncRNA和蛋白质在自调节中的作用.
主要成果:
- 自途径 (例如AMPK/mTOR) 的失调与DPN有关.
- 调节自的药物显示出促进神经再生的潜力.
- 外基因组, lncRNA 和蛋白质参与调节 DPN 中的自.
结论:
- 针对SCs的自是一种有希望的DPN治疗策略.
- 调节自为DPN治疗干预提供了新的见解.
- 需要进一步的研究来将这些发现转化为临床应用.
相关概念视频
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Diabetes: Management and Pharmacotherapy
410
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
410


